MER IMMUNOTHERAPY AND COMBINATION CHEMOTHERAPY FOR ADVANCED, RECURRENT HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY

被引:0
|
作者
VINCIGUERRA, V
COLEMAN, M
PAJAK, TF
RAFLA, S
STUTZMAN, L
GOMEZ, G
WEIL, M
BRUNNER, K
CUTTNER, J
NISSEN, N
LEVENTHAL, B
GOTTLIEB, A
机构
[1] NEW YORK HOSP,NEW YORK,NY 10021
[2] CANC & LEUKEMIA GRP B OPERAT OFF,SCARSDALE,NY 10583
[3] METHODIST HOSP,NEW YORK,NY
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
[5] HOP ST LOUIS,F-75475 PARIS 10,FRANCE
[6] INSELSPITAL,CH-3010 BERN,SWITZERLAND
[7] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
[8] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK
[9] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
[10] SUNY HOSP,UPSTATE MED CTR,SYRACUSE,NY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF M-AMSA THERAPY IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 7972
    RYBAK, ME
    ANDERSON, JR
    POULIN, RF
    AMREIN, PC
    CANELLOS, GP
    GOTTLIEB, AJ
    CANCER TREATMENT REPORTS, 1986, 70 (10): : 1233 - 1234
  • [32] COMBINATION CHEMOTHERAPY WITH ALTERNATING MOPP-ABVD IN ADVANCED HODGKINS-DISEASE
    BRUSAMOLINO, E
    LAZZARINO, M
    MORRA, E
    INVERARDI, D
    MERANTE, S
    CASTELLI, G
    CANEVARI, A
    DORNINI, G
    BERNASCONI, C
    HAEMATOLOGICA, 1989, 74 (02) : 173 - 179
  • [33] LONG-TERM EXPERIENCE WITH COMBINATION CHEMOTHERAPY IN ADVANCED HODGKINS-DISEASE
    GARRETT, MJ
    DAS, S
    SMITH, JD
    FREEDMAN, LS
    CLINICAL ONCOLOGY, 1977, 3 (02): : 145 - 154
  • [34] COMBINATION CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE IN RELAPSE FOLLOWING EXTENSIVE RADIOTHERAPY
    CANELLOS, GP
    YOUNG, RC
    DEVITA, VT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1972, 13 (05) : 750 - &
  • [35] COMBINATION CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE AFTER FAILURE OF MOPP - ABVD AND B-CAVE
    HARKER, WG
    KUSHLAN, P
    ROSENBERG, SA
    ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) : 440 - 446
  • [36] COMBINED MODALITY THERAPY OF ADVANCED RECURRENT HODGKINS-DISEASE - A RANDOMIZED TRIAL TESTING MER IMMUNOTHERAPY AND CHEMOTHERAPY OF CVPP, BAVS, AND ALTERNATING SEQUENCES OF CVPP-BAVS
    COLEMAN, M
    VINCIGUERRA, VP
    PAJAK, T
    GOTTLIEB, A
    RAFLA, S
    BLOOMFIELD, CD
    STUTZMAN, L
    CANCER TREATMENT REPORTS, 1982, 66 (04): : 1065 - 1065
  • [37] TREATMENT OF ADVANCED AND RECURRENT HODGKINS-DISEASE WITH CHLORAMBUCIL, VINBLASTINE, PROCARBAZINE AND PREDNISONE IN COMBINATION
    STOUT, R
    TODD, IDH
    CANCER TREATMENT REVIEWS, 1979, 6 : 107 - 113
  • [38] CYCLICAL COMBINATION CHEMOTHERAPY AND THYROID-FUNCTION IN PATIENTS WITH ADVANCED HODGKINS-DISEASE
    SUTCLIFFE, SB
    CHAPMAN, R
    WRIGLEY, PFM
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (05): : 439 - 448
  • [39] COMPARATIVE-STUDY OF A BCNU CONTAINING 4-DRUG PROGRAM VERSUS MOPP VERSUS 3-DRUG COMBINATIONS IN ADVANCED HODGKINS-DISEASE - COOPERATIVE STUDY BY THE CANCER AND LEUKEMIA GROUP-B
    NISSEN, NI
    PAJAK, TF
    GLIDEWELL, O
    PEDERSENBJERGAARD, J
    STUTZMAN, L
    FALKSON, G
    CUTTNER, J
    BLOM, J
    LEONE, L
    SAWITSKY, A
    COLEMAN, M
    HAURANI, F
    SPURR, CL
    HARLEY, JB
    SELIGMAN, B
    CORNELL, C
    HENRY, P
    SENN, H
    BRUNNER, K
    MARTZ, G
    MAURICE, P
    BANK, A
    SHAPIRO, L
    JAMES, GW
    HOLLAND, JF
    CANCER, 1979, 43 (01) : 31 - 40
  • [40] TREATMENT OF EXPERIMENTAL GROUP-B STREPTOCOCCAL (GBS) INFECTION WITH THE COMBINATION OF CHEMOTHERAPY AND IMMUNOTHERAPY
    KIM, KS
    KANG, JH
    WASS, CA
    CLINICAL RESEARCH, 1986, 34 (01): : A130 - A130